This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
A top Interface executive dumped stock in a move worth hundreds of thousands. Is this a signal about the business or ...
Today’s stock market today faces mixed signals as The Trade Desk slides on a Q1 miss and softer guidance. Here’s what...
Westport's Q4 2025 earnings release offers clues about growth, margins, and cash flow. This article breaks down the t...
A high-stakes dispute between MRED and Zillow has led to tens of thousands of Chicago listings being pulled from Zill...
A looming base oil shortage threatens routine oil changes as global supply tightens. The ‘imminent’ crisis isn’t pump...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Investors are eyeing space names as the industry expands. This guide dives into Redwire, asks if it can be a redwire ...
A Thursday rally put Oklo in the spotlight after a strategic supply agreement. This piece breaks down what happened, ...
In markets juggling record highs with recession fears, a few billionaire investors are doubling down on the backbone ...
Bank of America finished the Fed stress tests without a dividend hike while peers boosted payouts. Here’s what the ba...
Broadcom faced a rough June as the stock fell about 15%. This article breaks down what happened, why it matters, and ...